CD163 and Miyoshi myopathy: The prognostic relevance of M2 TAM in MM has been acknowledged by critical clinical studies that associated CD68/CD163 double-positive levels with an increased micro-vessel density and reduced survival, independent of the tumor stage (101–105), as angiogenesis induction is one of the mechanisms through which M2 TAM favors MM progression (104).